Cephalon Provigil Has 28% Awareness Among Primary Care Physicians
Executive Summary
Cephalon will step up its efforts to target primary care physicians in an effort to raise awareness about the sleep disorder agent Provigil (modafinil)
You may also be interested in...
Cephalon Stays Focused On Provigil; ADHD Launch Will Boost Sales Force 40%
Cephalon expects to increase its sales force by 40% in the second half of 2005 in order to support an upcoming launch of Provigil (modafinil) for pediatric attention deficit hyperactivity disorder
Cephalon Stays Focused On Provigil; ADHD Launch Will Boost Sales Force 40%
Cephalon expects to increase its sales force by 40% in the second half of 2005 in order to support an upcoming launch of Provigil (modafinil) for pediatric attention deficit hyperactivity disorder
Cephalon Marketing Under Investigation By Philadelphia U.S. Attorney
The Philadelphia U.S. Attorney's investigation into Cephalon's marketing practices covers the entire commercial life of Provigil